Danaher Corporation (DHR)

[jaj-dan]

Bad timing to drop $20 billion on a company purchase

[akamaii]

Let me guess the test that the cdc uses is Beckman coulter and it failed abbot nailed it why bc Danaher has issues on how they hire talent

[jaj-dan]

Close above $138.10 would be nice.

[jaj-dan]

https://www.google.com/amp/s/seekingalpha.com/amp/news/3555377-danaher-prices-1_7b-debt-offering

[jaj-dan]

Break and hold $132 would be a great sign here.

[bar1080]

Reuters: "Danaher Corp (DHR), which jumped 11.5% as its molecular diagnostics company Cepheid received the U.S. Food and Drug Administration's approval for the first rapid coronavirus diagnostic test."

[bar1080]

SA: "Danaher's Cepheid gets authorization for quicker Covid-19 test"

* The U.S. Food and Drug Administration issues the first emergency use authorization for a point-of-care Covid-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV 2 test.

* Cepheid is part of Danaher (NYSE:DHR).

* The test will provide results within hours, rather than days like existing tests, said HHS Secretary Alex Azar.

* Cepheid said the test has been designed to operate on any of its more than 23,000 automated GeneXpert Systems worldwide, with a detection time of ~45 minutes.

* The company plans to roll out the new test by March 30, the FDA said, while Cepheid said the test will begin shipping next week." more...

https://seekingalpha.com/news/3554024-danahers-cepheid-gets-authorization-for-quicker-covidminus-19-test

[jaj-dan]

The question is: will the current market allow this to explode on Monday?

And/or...

Will this gap up at the open of premarket and not allow anyone to jump in for the ride?

[bigstocksnbonds]

Thank you Very much for that excellent confirmation Summary! It is great news and much appreciated!

[bar1080]

"FDA Approves First Bedside Covid-19 Test by Danaher’s Cepheid"

"March 21, 2020, 1:08 PM CDT"

"A Covid-19 test can deliver results in less than an hour has been approved under an FDA emergency authorization, marking the first test that clinicians can use at the bedside.

Testing shortages have been an ongoing challenge in the U.S. response to curb the pandemic. The White House has promised testing will ramp up as more private companies come on board.

Public health and clinical labs have run more than 195,000 tests to date, but that doesn’t include hospital laboratories running their own test, Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services, said during a White House briefing Saturday.

Cepheid, a Silicon Valley molecular diagnostics company that’s a unit of Danaher Corp., announced Saturday it received an emergency authorization from the U.S. Food and Drug Administration to use the test, making it the 13th Covid-19 test the agency has allowed on the market as long as the public health emergency exists.

But it’s the first one that can be used at the point of care, meaning providers don’t have to send patient samples to a separate lab to be processed and then come back to the hospital or provider’s office. Cepheid said it expects to start shipping tests next week.

“An accurate test delivered close to the patient can be transformative—and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources,” David Persing, Cepheid chief medical and technology officer."

https://www.bloomberg.com/news/articles/2020-03-21/fda-approves-first-bedside-covid-19-test-by-cepheid

[bigstocksnbonds]

Rusty8350–Thank you very much for confirming that and also for the heads up about Biomerieux! I appreciate both much!

[rusty8350]

Yes - this is the company that owns Cepheid and their testing platform genexpert is in almost any hospital and WILL be what most hospitals use for the testing for covid19 in house. Biomerieux is another company that has the bio fire test that will likely be approved soon as well. Almost everyone uses that platform as well and it would be even more likely to be used as they have a panel test that could test for this strain of Coronavirus as well as many other viruses that could cause illnesses all at once.

[bigstocksnbonds]

Did DHR just get approval by FDA this weekend for a novel effective 45 minute corona virus detection kit please? I read that Cepheid Co got FDA approval but that they were bought by DHR a few years back! Will DHR soar Monday am? Do you have knowledge of what I mentioned please? Thank you much!

[bar1080]

DHR has performed beautifully. Still outperforming the broad market even since CV hit. Dividend looks solid for now.

[akamaii]

124

[akamaii]

Smart guy and a pos company

[akamaii]

Ok lol

[akamaii]

How’s that record high working bud

[akamaii]

28 now lol

[akamaii]

40 dollars away

[Xpecht]

Thanks for doing the research on this...we shall see!

[bar1080]

"... FDA said in a statement that state and local public health labs will be able to test up to 75,000 people by the end of the week. That spokesperson added that a commercial manufacturer, IDT is producing additional CDC tests and expects to have shipped test kits capable of about 1 million tests to academic, healthcare and commercial labs by the week's end."

https://www.cnn.com/2020/03/03/politics/pence-coronavirus-any-american-tested/index.html

[bar1080]

Good find, perhaps: "IDT manufactures products used in diagnostic tests for many forms of cancer and most inherited and infectious diseases. In addition, researchers involved with the National Institutes of Health Human Microbiome Project are using our products to further the understanding of human microbiota diversity."

https://www.danaher.com/our-businesses/life-sciences/integrated-dna-technologies-idt

I didn't hear VP Pence but I'll do some research

[Xpecht]

Anyone know if the acquisition of IDT (integrated DNA technologies)back in 2018 by this company. Is this the same IDT company who VP Mike Pence just mentioned in the press conference as the company providing the Covid 19 test kits?

[akamaii]

100 price target in a year watch and learn kids

[akamaii]

Pos company anyways

[bar1080]

Damn. Double damn. Record high at $156.30

[bar1080]

$150 is new record high for DHR.

[DeafTrader2]

BEAST MODE EVER MORE FOR YEARS TO COME ..


H2O is the most important element on planet ..


Oh my gosh ...

[bar1080]

$147: New Record High for Danaher

[TFMG]

DHR WILL BE A GREAT SHORT ON ANY MARKET WEAKNESS

Despite the acquisition of GE Biopharma the stock performance this year is hard to quantify, it does seem that it has ran a little too far to fast and needs a healthy pullback. We assume that when the selling does start it could snowball into quite a drop as large profits are banked and sellers find it hard to offload their portfolio. We will be looking at this as a short when the indicators become more oversld

[bar1080]

$137 is a new record high for my DHR

[bar1080]

"Danaher (NYSE:DHR) declares $0.17/share quarterly dividend, 6.3% increase from prior dividend of $0.16."

[bar1080]

My Lord! $123.00

[bar1080]

Make that $108, not $208.

[bar1080]

Record high for Danaher at $208. Anyone else own this longtime winner?

[jmgreeny]

Can anyone explain how you beat expectations clearly. Then stock goes south 15%. The fundamentals and my DD sees growth not reversal

[DewDiligence]

DHR 4Q17 results:

https://finance.yahoo.com/news/danaher-reports-fourth-quarter-full-110000992.html

DHR logged double-digit growth in emerging markets for 4Q17 and full-year 2017.

Inasmuch as DHF pre-announced strong 4Q17 results at the JPM conference in mid-January (#msg-137540935), the selloff today is not surprising.

[DewDiligence]

DHR +3% to new high on 4Q17 earnings above prior guidance:

https://finance.yahoo.com/news/danaher-ceo-financial-performance-010500323.html

This PR was released in conjunction with the JPM webcast.

[DewDiligence]

Transcript of 3Q17 CC:

https://finance.yahoo.com/news/edited-transcript-dhr-earnings-conference-235448375.html

[DewDiligence]

DHR 3Q17 results...

PR:
https://finance.yahoo.com/news/danaher-reports-third-quarter-2017-100000150.html

CC slides:
http://investors.danaher.com/image/3Q2017+DHR+Earnings+Presentation.pdf

[DewDiligence]

Transcript of DHR 2Q17 CC:

https://finance.yahoo.com/news/edited-transcript-dhr-earnings-conference-174538633.html

[DewDiligence]

DHR 2Q17 results:

https://finance.yahoo.com/news/danaher-reports-second-quarter-2017-100000219.html

[DewDiligence]

DHR write-up in TMF echoes stuff previously posted on iHub: #msg-132822622.

[DewDiligence]

FDA approves Beckman Coulter test for leukemia/lymphoma:

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm565321.htm

[DewDiligence]

DHR’s Sciex gets China approval for high-end mass-spec/liquid-chrom device:

#msg-132602984

[DewDiligence]

DHR CC slides from GS webcast (6/14/17):

http://investors.danaher.com/image/2017+Danaher+at+Goldman+Sachs+Healthcare.pdf

[DewDiligence]

DHR 1Q17 CC slides:

http://investors.danaher.com/image/1Q2017+Danaher+Earnings+Presentation.pdf

[DewDiligence]

Bought new position today at 86.41-86.51.

[DewDiligence]

DHR sells €600M ($675M) of 10-year bonds at 1.2%:

https://finance.yahoo.com/news/danaher-announces-pricing-euro-denominated-121100751.html

They also sold €250M of 5-year floating-rate notes. The proceeds will be used, in part, to repay maturing debt securities.